Upload
ariel-cobb
View
215
Download
0
Tags:
Embed Size (px)
Citation preview
Prevention of Ovarian Cancer
Roberta B. Ness, M.D., M.P.H.,
Chair of the Department of
Epidemiology, University of
Pittsburgh, Graduate School of Public
Health
What Puts Women at Risk?
• Family history of ovarian and breast cancers
• Infertility
• Endometriosis
• Talc use
• Hormone replacement therapy
Does Anything Prevent Ovarian Cancer?
• Oral contraceptives
• Pregnancies
• Breast feeding (long duration)
• Tubal ligation
• Oophorectomy and hysterectomy
Probability of a 50 yo Non-Jewish Woman with Ovarian Cancer Carrying a BRCA1 Mutation
8% 10%
20%
40%
0%
5%
10%
15%
20%
25%
30%
35%
40%
No affectedrelatives
1 relativeBreast Ca
1 relativeOvarian Ca
1 relativeBreast &
Ovarian Ca
Probability of a 50 yo Jewish Woman with Ovarian Cancer Carrying a BRCA1 Mutation
30%40%
55%
78%
0%
10%
20%
30%
40%
50%
60%
70%
80%
No affectedrelatives
1 relativeBreast Ca
1 relativeOvarian Ca
1 relativeBreast &
Ovarian Ca
The Legacy of BRCA
BRCA1: Lifetime Risk of Ovarian Cancer:28-66%
BRCA2: Risk by age 50: <1%But by age 70: 27%
Infertility and Ovarian Cancer Risk
Compared to women with 3 or more pregnancies…
RISKWomen with 0 pregnancies
not trying 2.1
Women with 0 pregnanciestrying 4.3
Hypotheses (New)
• Inflammation: Pelvic inflammation exposes the lining of the ovary to toxic mediators and makes cells quickly turnover. Both may be mutagenic.
Etiologic Hypotheses (New)
Androgens and Progestins
• Androgen exposure elevates risk
• Progestins reduce risk
Oral Contraceptives and Ovarian Cancer
• Risk 30-40% • Longer use, more protection
• Protection 20 or more years after last use
• New OCs protective
• May be best: low estrogen
high progestin
Pregnancies and Ovarian Cancer
00,10,20,30,40,50,60,70,80,9
1
0 1 2 3 4 5 6
Number of pregnancies
Ris
k
Breast Feeding and Ovarian Cancer
00,10,20,30,40,50,60,70,80,9
1
Number of months breastfeeding
Ris
k
0 6 12 18 24
OophorectomyC
um
ula
tive
Pro
por
tion
wit
hou
t B
reas
t or
B
RC
A-R
elat
ed G
ynec
olog
ic C
ance
r Salpingo-oophorectomy (n=98)
Months0 12 24 36 48 60 72 84
1.0
0.9
0.8
0.7
0.6Surveillance (n=72)
Oral Contraception in Women with
BRCA Mutations or Family HistoryModan (2001)
•Women without mutations protected
•Women with mutations not protected
Narod (1998)
•All women with or without BRCA mutations protected
Walker (2002)
•All women with or without family history protected
Tubal Ligation in BRCA Carriers
1,0
0,4 0,3
0,0
0,2
0,4
0,6
0,8
1,0
No tuballigation
Tubal Tubal +OCs
Aspirin Use
Tzonou Cramer Rosenberg Tavani Akhmed Moysich
1984 1998 2000 2000 2001 2001
Risk 1.0 0.9 0.9
0.75 X X
X 0.7 0.6
0.5 X X
X
khanov
What Can You (and Yours) Change?
Anyone
• Oral Contraceptive Use• Pregnancies and Breast Feeding• Tubal Ligation• Don’t Use Talc• Don’t Use HRT (except for perimenopausal symptoms)